HBEAG SEROCONVERSION RATES AFTER FIVE YEARS OF FOLLOW-UP IN PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (40KD) IN NEPTUNE: FINAL RESULTS OF THE SON OF NEPTUNE LONG-TERM FOLLOW-UP STUDY
单位：[1]Department ofInternal Medicine, Kaohsiung Medical University Hospital, KaohsiungMedical University, Kaohsiung, Taiwan[2]Liver Research Center, BeijingFriendship Hospital, Capital Medical University, Beijing临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[3]Department ofMedicine and Therapeutics, Institute of Digestive Disease and State KeyLaboratory of Digestive Disease, The Chinese University of Hong Kong,Hong Kong, China[4]Department of Internal Medicine, Yonsei UniversityCollege of Medicine, Seoul, South Korea[5]Division of Gastroenterology,Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok,Thailand[6]Department of Infectious Diseases, Xiangya Hospital, CentralSouth University, Changsha[7]Department of Hepatology, Beijing YouanHospital, Capital Medical University, Beijing, China[8]Auckland ClinicalStudies, Grafton, New Zealand[9]NKC Institute of Gastroenterology andHepatology, Prince of Songkla University, Hat-Yai, Thailand[10]ShanghaiPublic Health Clinical Center, Fudan University[11]Department ofInfectious Diseases, Shanghai Ruijin Hospital, Jiaotong University Schoolof Medicine, Shanghai[12]Department of Medicine and Therapeutics andInstitute of Digestive Disease, Chinese University of Hong Kong, HongKong SAR, China[13]PROMETRIS GmbH, Mannheim, Germany[14]RocheProducts Ltd., Welwyn Garden City, United Kingdom[15]F. Hoffmann-LaRoche Ltd, Basel, Switzerland[16]Liver Research Unit, Chang GungMemorial Hospital, Chang Gung University College of Medicine, Taipei,Taiwan中山大学附属第二医院
第一作者单位：[1]Department ofInternal Medicine, Kaohsiung Medical University Hospital, KaohsiungMedical University, Kaohsiung, Taiwan
推荐引用方式(GB/T 7714)：
W.-L. Chuang,J. Jia,H.L.-Y. Chan,et al.HBEAG SEROCONVERSION RATES AFTER FIVE YEARS OF FOLLOW-UP IN PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (40KD) IN NEPTUNE: FINAL RESULTS OF THE SON OF NEPTUNE LONG-TERM FOLLOW-UP STUDY[J].JOURNAL of HEPATOLOGY.2016,64:S604-S604.doi:10.1016/S0168-8278(16)01116-8.
APA：
W.-L. Chuang,J. Jia,H.L.-Y. Chan,K.-H. Han,T. Tanwandee...&Y.-F. Liaw.(2016).HBEAG SEROCONVERSION RATES AFTER FIVE YEARS OF FOLLOW-UP IN PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (40KD) IN NEPTUNE: FINAL RESULTS OF THE SON OF NEPTUNE LONG-TERM FOLLOW-UP STUDY.JOURNAL of HEPATOLOGY,64,
MLA：
W.-L. Chuang,et al."HBEAG SEROCONVERSION RATES AFTER FIVE YEARS OF FOLLOW-UP IN PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (40KD) IN NEPTUNE: FINAL RESULTS OF THE SON OF NEPTUNE LONG-TERM FOLLOW-UP STUDY".JOURNAL of HEPATOLOGY 64.(2016):S604-S604
医学